NCT02993575 Pharmacokinetics of Flucloxacillin Given by Continuous or Intermittent Infusion to ICU Patients Status COMPLETED Phase N/A
NCT02955459 VNRX-5133 SAD/MAD Safety and PK in Healthy Adult Volunteers Status COMPLETED Phase PHASE1
NCT02877927 Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI Status COMPLETED Phase PHASE3
NCT02852902 Impact of Specific Antimicrobials and MIC Values on the Outcome of Bloodstream Infections Due to ESBL- or Carbapenemase-producing Enterobacterales in Solid Organ Transplantation: an Observational Multinational Study. Status COMPLETED Phase N/A
NCT02848534 The Value of the Neutrophil to Lymphocyte Ratio in the Diagnosis of Bacterial Infections Status COMPLETED Phase N/A
NCT02837081 Preauthorization Versus Prospective Audit in Antimicrobial Stewardship Program Status UNKNOWN Phase NA
NCT02814916 Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA Status COMPLETED Phase PHASE3
NCT02688790 Study Evaluate the PK Profile of Dalbavancin in Infants and Neonates Patients With Known or Suspected Bacterial Infection Status TERMINATED Phase PHASE1
NCT02687906 Dose-finding, Pharmacokinetics, and Safety of VABOMERE in Pediatric Subjects With Bacterial Infections Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT02655302 Study of the Involvement of IL-17 / IL-22 Pathway in Bacterial Exacerbations of COPD Status TERMINATED Phase NA
NCT02541695 Characterization of Resistance Against Live-attenuated Diarrhoeagenic E. Coli Status COMPLETED Phase NA
NCT02527681 Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics Status TERMINATED Phase PHASE1
NCT02475876 PK of Clindamycin and Trimethoprim-sulfamethoxazole in Infants and Children Status COMPLETED Phase PHASE1
NCT02452047 Efficacy and Safety of Imipenem+Cilastatin/Relebactam (MK-7655A) Versus Colistimethate Sodium+Imipenem+Cilastatin in Imipenem-Resistant Bacterial Infection (MK-7655A-013) Status COMPLETED Phase PHASE3
NCT02378480 Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23) Status COMPLETED Phase PHASE3
NCT02361866 To Evaluate the Effectiveness(Immunogeneicity) and Safety of 'GC1107' Administered Intramuscularly in Healthy Adults Status COMPLETED Phase PHASE3
NCT02306330 MALDITOF Versus Routine Clinical Microbiology for Identifying Pathogens; a Randomized Diagnostic Trial Status COMPLETED Phase NA